Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
24 Feb 2021 |
About corporate governance |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
|
27 Nov 2020 |
On business and financial situation |
The Company publishes the results of the PRISMA-3 study of the efficacy and safety of Doria® in schizophrenic patients in the journal npj Schizophrenia
|
Download |
|
09 Jul 2020 |
On business and financial situation |
ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
15 Feb 2022 |
On business and financial situation |
ROVI has announced that the European Commission has authorised the marketing of Okedi® for the treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.
|
Download |
|
14 Feb 2022 |
Share buy-back , stabilisation and treasury stock programme |
Share Buyback Program: transactions conducted between 7 February 2022 and 11 February 2022
|
Download |
|
07 Feb 2022 |
Share buy-back , stabilisation and treasury stock programme |
Share Buyback Program: transactions conducted between 31 January 2022 and 4 February 2022
|
Download |
|
31 Jan 2022 |
Share buy-back , stabilisation and treasury stock programme |
Share Buyback Program: transactions conducted between 24 January 2022 and 28 January 2022
|
Download |
|
24 Jan 2022 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 17 January 2022 and 21 January 2022
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
05 Oct 2017 |
Contratos de liquidez y contrapartida |
Liquidity contract: modification of transactions conducted from 11 July to 30 September 2017.
|
Download |
|
03 Oct 2017 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted from 11 July to 30 September 2017
|
Download |
|
07 Sep 2017 |
Otros sobre negocio y situación financiera |
The Company informs that commences the enoxaparin biosimilar marketing in Germany
|
Download |
|
26 Jul 2017 |
Información sobre resultados |
ROVI releases the presentation related to the 2017 first half results
|
Download |
|
26 Jul 2017 |
Información sobre resultados |
ROVI releases the presentation related to the 2017 first half results
|
Download |
Pages
